معرفی
Eugenia Chock is an Assistant Professor of Medicine in the Section of Rheumatology, Allergy, and Immunology at Yale School of Medicine. She is affiliated with the Department of Internal Medicine and is part of the Antiphospholipid Syndrome Program and the Janeway Society. Her clinical and research work is centered at Yale, where she contributes to advancing knowledge in reproductive rheumatology and autoimmune diseases.
- MD, Dalhousie University (2008)
- Residency, New York Presbyterian (2013)
- MPH, Johns Hopkins Bloomberg School of Public Health
- Fellowship, Yale School of Medicine (2016)
Dr. Chock's research focuses on reproductive rheumatology, particularly the effects of antirheumatic medications on offspring outcomes. She has a strong interest in leveraging large datasets and conducting systematic reviews and meta-analyses to understand disease patterns and treatment impacts in patients with systemic autoimmune conditions such as lupus and antiphospholipid syndrome. Her work bridges clinical care and population health, with a special emphasis on maternal and child health in the context of chronic inflammation.
Her recent publications span topics including antiphospholipid antibody nephropathy, proteomic profiling in autoimmune phenotypes, neurodevelopmental outcomes in children of affected parents, and the impact of the COVID-19 pandemic on rheumatic disease patients. These studies reflect a consistent focus on autoimmune mechanisms, renal pathology, reproductive health, and digital health innovations like telemedicine. Her collaborative research network includes key figures in rheumatology and immunology at Yale and globally.
While no specific scientific awards are listed, her active involvement in national and international research consortia underscores her recognition in the field.
Dr. Chock is engaged in clinical research through the Yale Lupus and Connective Tissue Disease Bio-Repository, where she serves as a Sub-Investigator. She is involved in studies related to immune system dysregulation and long-term outcomes in autoimmune diseases, contributing to both data collection and analysis. Her work supports larger efforts in precision medicine and patient-centered outcomes in rheumatology.
She is a board-certified specialist in both Internal Medicine and Rheumatology by the American Board of Internal Medicine, with certifications obtained in 2013 and 2018 respectively. Her clinical expertise includes the diagnosis and management of lupus, arthritis, and related connective tissue disorders.
